A meta-analysis published in 2021 [23] reported that in the DOR population, the PPOS protocol resulted in a lower incidence of early-onset luteinising hormone (LH) peaks and ovarian hyperstimulation syndrome than did the GnRH antagonist regimen, GnRH agonist regimen, and natural cycle. This evidence concerns the gene PLOD1 and ovarian hyperstimulation syndrome.